Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA).
- Disclosed ownership: 5.5%.
- Date of event: 14 Nov 2025.
PERCEPTIVE ADVISORS LLC - 14 Nov 2025 SCHEDULE 13D/A Report for Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- LYRA
- Shares outstanding
- 1,787,291 shares
- Disclosed Ownership
- 98,301 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13D/A
- Filing time
- 18 Nov 2025, 16:14:27 UTC
- Date of event
- 14 Nov 2025
- Previous filing
- 13 Nov 2025
- Next filing
- 25 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 5.5% ownership in Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA) on 14 Nov 2025."
What Changed
- Previous schedule filing date: 13 Nov 2025.
- Current filing was accepted on 18 Nov 2025, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 5.5% | 98,301 | 0 | 98,301 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001224962 |
| Joseph Edelman | 5.5% | 98,301 | 0 | 98,301 | /s/ Joseph Edelman | Joseph Edelman | 0001164426 |
| Perceptive Life Sciences Master Fund, Ltd. | 5% | 88,374 | 0 | 88,374 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001249675 |
| Perceptive LS (A), LLC | 0.6% | 9,927 | 0 | 9,927 | Perceptive LS GP, LLC | Joseph Edelman, Member | 0001797811 |